BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22764249)

  • 1. Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment.
    Zhu J; Zhang X; Xu Y; Spencer TJ; Biederman J; Bhide PG
    J Neurosci; 2012 Jul; 32(27):9410-8. PubMed ID: 22764249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prenatal nicotine exposure mouse model of methylphenidate responsive ADHD-associated cognitive phenotypes.
    Zhu J; Fan F; McCarthy DM; Zhang L; Cannon EN; Spencer TJ; Biederman J; Bhide PG
    Int J Dev Neurosci; 2017 May; 58():26-34. PubMed ID: 28179105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental nicotine exposure precipitates multigenerational maternal transmission of nicotine preference and ADHD-like behavioral, rhythmometric, neuropharmacological, and epigenetic anomalies in adolescent mice.
    Buck JM; Sanders KN; Wageman CR; Knopik VS; Stitzel JA; O'Neill HC
    Neuropharmacology; 2019 May; 149():66-82. PubMed ID: 30742847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.
    Alkam T; Mamiya T; Kimura N; Yoshida A; Kihara D; Tsunoda Y; Aoyama Y; Hiramatsu M; Kim HC; Nabeshima T
    Psychopharmacology (Berl); 2017 Jun; 234(12):1853-1869. PubMed ID: 28332006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prenatal exposure to tobacco smoke on inhibitory control: neuroimaging results from a 25-year prospective study.
    Holz NE; Boecker R; Baumeister S; Hohm E; Zohsel K; Buchmann AF; Blomeyer D; Jennen-Steinmetz C; Hohmann S; Wolf I; Plichta MM; Meyer-Lindenberg A; Banaschewski T; Brandeis D; Laucht M
    JAMA Psychiatry; 2014 Jul; 71(7):786-96. PubMed ID: 24828276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring.
    Kim P; Choi CS; Park JH; Joo SH; Kim SY; Ko HM; Kim KC; Jeon SJ; Park SH; Han SH; Ryu JH; Cheong JH; Han JY; Ko KN; Shin CY
    J Neurosci Res; 2014 May; 92(5):658-70. PubMed ID: 24510599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attention and working memory deficits in a perinatal nicotine exposure mouse model.
    Zhang L; Spencer TJ; Biederman J; Bhide PG
    PLoS One; 2018; 13(5):e0198064. PubMed ID: 29795664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenerational transmission of hyperactivity in a mouse model of ADHD.
    Zhu J; Lee KP; Spencer TJ; Biederman J; Bhide PG
    J Neurosci; 2014 Feb; 34(8):2768-73. PubMed ID: 24553919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cingulate impairments in ADHD: Comorbidities, connections, and treatment.
    Vogt BA
    Handb Clin Neurol; 2019; 166():297-314. PubMed ID: 31731917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal nicotine exposure and child behavioural problems.
    Tiesler CM; Heinrich J
    Eur Child Adolesc Psychiatry; 2014 Oct; 23(10):913-29. PubMed ID: 25241028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontal Cortical Monoamine Release, Attention, and Working Memory in a Perinatal Nicotine Exposure Mouse Model Following Kappa Opioid Receptor Antagonism.
    Zhang L; McCarthy DM; Eskow Jaunarajs KL; Biederman J; Spencer TJ; Bhide PG
    Cereb Cortex; 2021 Jan; 31(1):483-496. PubMed ID: 32869057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K; Halari R; Mohammad AM; Taylor E; Brammer M
    Biol Psychiatry; 2011 Aug; 70(3):255-62. PubMed ID: 21664605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical Models of Attention Deficit Hyperactivity Disorder: Neurobiology, Drug Discovery, and Beyond.
    McCarthy DM; Spencer TJ; Bhide PG
    J Atten Disord; 2024 Mar; 28(5):880-894. PubMed ID: 38084074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal methylphenidate exposure induced ADHD-like phenotypes and decreased Drd2 and Slc6a3 expression levels in mouse offspring.
    Aoki S; Kaizaki-Mitsumoto A; Hattori N; Numazawa S
    Toxicol Lett; 2021 Jun; 344():1-10. PubMed ID: 33647392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal nicotine exposure in mice induces sex-dependent anxiety-like behavior, cognitive deficits, hyperactivity, and changes in the expression of glutamate receptor associated-genes in the prefrontal cortex.
    Polli FS; Scharff MB; Ipsen TH; Aznar S; Kohlmeier KA; Andreasen JT
    Pharmacol Biochem Behav; 2020 Aug; 195():172951. PubMed ID: 32439454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of learning and increase in dopamine level in the frontal cortex by methylphenidate in mice lacking dopamine transporter.
    Takamatsu Y; Hagino Y; Sato A; Takahashi T; Nagasawa SY; Kubo Y; Mizuguchi M; Uhl GR; Sora I; Ikeda K
    Curr Mol Med; 2015; 15(3):245-52. PubMed ID: 25817856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Psychopharmacology (Berl); 2004 Nov; 176(2):182-94. PubMed ID: 15083253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodent models of attention-deficit hyperactivity disorder: An updated framework for model validation and therapeutic drug discovery.
    Kantak KM
    Pharmacol Biochem Behav; 2022 May; 216():173378. PubMed ID: 35367465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
    Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.